Related Experiment Video
Updated: Jun 13, 2025
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Stepwise approach to screen high-risk individuals using the non-laboratory-based and laboratory-based CVD risk
Noushin Fahimfar1,2, Sareh Eghtesad3, Hossein Poustchi3
1Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 1411713119, Iran.
Objective:
We compared non-laboratory models' efficacy with standard laboratory-based model in identifying high-risk populations for cardiovascular disease (CVD) in resource-limited settings.
Methods:
A national sample of 121 672 individuals aged 40-70 from the PERSIAN cohort was analyzed. Non-laboratory models, including the World Health Organization (WHO) and Iranian pooled-cohort CVD mortality models, were compared with the WHO laboratory-based model. Intra-class correlation coefficient (ICC) and concordance correlation coefficient (CCC) were utilized. Sensitivity and specificity of non-laboratory models were evaluated against the laboratory-based one at various risk thresholds. The number of reduced tests in the stepwise approach was calculated considering the Iranian census.
Results:
Both non-laboratory and laboratory-based models showed similar trends in predicting CVD risks across age groups. Strong correlations and concordance were observed in both men (ICC: 94.4%, CCC:0.893) and women (ICC: 93.8%, CCC:0.883). Utilizing a 5% risk threshold for WHO non-laboratory and 2% for the Iranian pooled-cohort CVD mortality model as the initial step achieved high sensitivity (99.6%) and moderate specificity (52%) for identifying candidates for the second-step laboratory test. This approach effectively reduced the number of tests by 16 807 982.
Conclusion:
Non-laboratory models, in a stepwise approach, offer a promising strategy to alleviate strain on financial resources and enhance healthcare system efficiency in resource-limited countries.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
01:23Assessment of blood pressure in brachial artery(two-step method)
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Assessment of the Cardiovascular System II: Inspection
Head and Neck
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...